Artiva (ARTV) COO Jennifer Bush Sells 8,391 Shares

What Happened Jennifer Bush, Artiva Biotherapeutics' Chief Operating Officer, Chief Legal Officer and Compliance Officer, sold 8,391 shares on 2026-09-03. The reported weighted-average sale price was $11.1555 (range $11.0350–$11.1556), producing roughly $93,606 in proceeds. This was a sale (not a purchase) and was reported as an automatic sell-to-cover related to the vesting and release of restricted stock units.

Key Details

• Transaction date: 2026-09-03; Form 4 filed: 2026-09-04 (filed promptly the next day).
• Transaction type: Sale (listed as "open market or private sale" on the Form 4).
• Shares sold: 8,391 at a weighted average price of $11.1555; price range $11.0350–$11.1556; proceeds ≈ $93,606.
• Shares owned after transaction: Not specified in the information provided.
• Footnotes: F1 — sale was automatic under the issuer’s sell-to-cover policy to satisfy tax withholding on vested RSUs (not at the insider’s discretion). F2 — weighted average and price range disclosed; further per-share breakdown available on request.

Context Sell-to-cover transactions are routine when restricted stock units vest and do not necessarily indicate the insider’s view on the company’s prospects. Purchases are generally more informative about bullish sentiment; this transaction reflects tax withholding mechanics rather than an affirmative buy or directional trade.